These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 16752412)

  • 21. RANK, RANKL, OPG, and M-CSF expression in stromal cells during corneal wound healing.
    Wilson SE; Mohan RR; Netto M; Perez V; Possin D; Huang J; Kwon R; Alekseev A; Rodriguez-Perez JP
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2201-11. PubMed ID: 15223796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis.
    Crotti T; Smith MD; Hirsch R; Soukoulis S; Weedon H; Capone M; Ahern MJ; Haynes D
    J Periodontal Res; 2003 Aug; 38(4):380-7. PubMed ID: 12828654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.
    Nakashima T; Kobayashi Y; Yamasaki S; Kawakami A; Eguchi K; Sasaki H; Sakai H
    Biochem Biophys Res Commun; 2000 Sep; 275(3):768-75. PubMed ID: 10973797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential role of the OPG/RANK/RANKL axis in prostate cancer invasion and bone metastasis.
    Li X; Liu Y; Wu B; Dong Z; Wang Y; Lu J; Shi P; Bai W; Wang Z
    Oncol Rep; 2014 Dec; 32(6):2605-11. PubMed ID: 25333856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
    Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D
    Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
    Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
    J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure.
    Ueland T; Yndestad A; Øie E; Florholmen G; Halvorsen B; Frøland SS; Simonsen S; Christensen G; Gullestad L; Aukrust P
    Circulation; 2005 May; 111(19):2461-8. PubMed ID: 15883214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
    Nyambo R; Cross N; Lippitt J; Holen I; Bryden G; Hamdy FC; Eaton CL
    J Bone Miner Res; 2004 Oct; 19(10):1712-21. PubMed ID: 15355567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1alpha,25-dihydroxyvitamin D3.
    Zhang D; Yang YQ; Li XT; Fu MK
    Arch Oral Biol; 2004 Jan; 49(1):71-6. PubMed ID: 14693199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat.
    Silvestrini G; Ballanti P; Patacchioli F; Leopizzi M; Gualtieri N; Monnazzi P; Tremante E; Sardella D; Bonucci E
    J Mol Histol; 2005 Feb; 36(1-2):59-67. PubMed ID: 15704000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor.
    Yamada N; Tsujimura T; Ueda H; Hayashi S; Ohyama H; Okamura H; Terada N
    Cytokine; 2005 Aug; 31(4):288-97. PubMed ID: 15996478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones.
    Swanson C; Lorentzon M; Conaway HH; Lerner UH
    Endocrinology; 2006 Jul; 147(7):3613-22. PubMed ID: 16614077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
    Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene.
    Cheung J; Mak YT; Papaioannou S; Evans BA; Fogelman I; Hampson G
    J Endocrinol; 2003 Jun; 177(3):423-33. PubMed ID: 12773123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease.
    Sattler AM; Schoppet M; Schaefer JR; Hofbauer LC
    Calcif Tissue Int; 2004 Jan; 74(1):103-6. PubMed ID: 14523602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum osteoprotegerin and receptor activator of nuclear factor-kappa B ligand as indicators of disturbed osteoclastogenesis in patients with prostate cancer.
    Jung K; Stephan C; Semjonow A; Lein M; Schnorr D; Loening SA
    J Urol; 2003 Dec; 170(6 Pt 1):2302-5. PubMed ID: 14634401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of baicalin on the expression of receptor activator of nuclear factor-kappaB ligand in cultured human periodontal ligament cells.
    Wang GF; Wu ZF; Wan L; Wang QT; Chen FM
    Pharmacology; 2006; 77(2):71-7. PubMed ID: 16636611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long wave ultrasound may enhance bone regeneration by altering OPG/RANKL ratio in human osteoblast-like cells.
    Maddi A; Hai H; Ong ST; Sharp L; Harris M; Meghji S
    Bone; 2006 Aug; 39(2):283-8. PubMed ID: 16567138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.
    Theoleyre S; Wittrant Y; Tat SK; Fortun Y; Redini F; Heymann D
    Cytokine Growth Factor Rev; 2004 Dec; 15(6):457-75. PubMed ID: 15561602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement.
    Mandelin J; Li TF; Liljeström M; Kroon ME; Hanemaaijer R; Santavirta S; Konttinen YT
    J Bone Joint Surg Br; 2003 Nov; 85(8):1196-201. PubMed ID: 14653607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.